A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust pain relief for up to three weeks, according to the results of preclinical ...
After facing weeks of pushback, health insurer Anthem Blue Cross Blue Shield said Thursday it will not go ahead with a policy change that would have limited reimbursements for anesthesia during ...
Please provide your email address to receive an email when new articles are posted on . A strategy of local anesthesia without sedation was safe vs. conscious sedation for patients undergoing TAVR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results